Celebrating Journal of Human Immunity’s Successful Launch Year

Dear members of the JProject Society and Bulgarian Association of Clinical Immunology,

As we close 2025, we are proud to reflect on the Journal of Human Immunity’s (JHI) inaugural year. JHI is already establishing itself as a trusted, open access journal for rigorous research in human inborn errors of immunity (IEI), including primary immunodeficiencies, autoimmunity, autoinflammation, malignancy, and allergy. We thank you for your support during this foundational year, and we are pleased to share the five most-read articles to date:

• Human inborn errors of immunity: 2024 update on the classification from the International Union of Immunological Societies Expert Committee
• The 2024 update of IUIS phenotypic classification of human inborn errors of immunity
• Inborn errors of immunity: Manifestation, treatment, and outcome—an ESID registry 1994–2024 report on 30,628 patients
• Prevalence and association of type I IFN autoantibodies with clinical outcomes in critically ill Brazilian COVID-19 patients
• Revisiting X-linked agammaglobulinemia

Stay Informed
To receive updates about new content published in JHI, we encourage all of you to register for email alerts.

Support Your Journal: Publish In JHI
JHI is the official journal of International Alliance for Primary Immunodeficiency Societies (IAPIDS) and JProject Society. As a journal by and for scientists, editorial decisions are determined by active researchers not commercial interests. Support your journal and your community by submitting to JHI. The society’s members] receive a discount on the article processing charge (APC). For corresponding authors from institutions in low- or middle-income countries, APCs are automatically waived. Learn more about publishing in JHI here.

Connect and Share

• Twitter/X: @jhumimmunity
• Bluesky: @jhumimmunity.org

Thank you for being part of this exciting beginning. Your involvement, whether through publishing, reading, or sharing, builds on this momentum, and we look forward to accomplishing more in 2026.

JHI Associate Editor
Elissaveta Naumova,MD,DSci